Bridging domains: The untapped potential of AI-driven assess...

The progression of artificial intelligence in healthcare has largely occurred in silos, with innovations developing within specific medical domains, rather than across them.

The TechBio way: Brendan Frey talks genomics, AI, and RNA

pharmaphorum speaks with Brendan Frey, founder and chief innovation officer of Deep Genomics, an AI-first TechBio organisation.

Smarter learning and better outcomes: How AI can provide an ...

AI is revolutionising medical education, optimising learner outcomes and, ultimately, improving real-world patient care.

Digital marketing worked. Now pharma must reorganise around ...

Remember when I said that patients are coming to doctors with formed opinions – if they come to physicians at all?

We can’t fix modern healthcare with 1950s solutions. AI is t...

In today’s NHS, the urgency of embracing artificial intelligence (AI) is no longer a matter of innovation - it’s a matter of survival.

HLTH Europe: What drives strong pharma-tech collabs